fr

CARMAT receives FDA conditional approval to initiate the second cohort of the EFS study in the United States

CARMAT appoints Wenzel Hurtak as Director of Manufacturing

Download

CARMAT announces the resumption of the PIVOTAL study in France

Download

2016 full-year results

Download

CARMAT provides an update regarding the suspended PIVOTAL study on its bioprosthetic artificial heart

Download

Two cardiology experts join CARMAT’s Board of Directors as independent members

Download

Update on the PIVOTAL study on the CARMAT bioprosthetic artificial heart

Download

2016 half-year results

Download

Stéphane Piat has been appointed CEO of CARMAT

Download
Top of page